Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”

A look at the specialty landscape and how Prime delivers value to employers

What works and what doesn’t

Magellan Rx's businesses includes a 1.7-million member PBM. The deal is struck amid a long-time trend toward consolidation in the pharmacy benefit management industry

cover image for Trending Topics & Drug Approvals: June 2025 Your source for the latest drug information highlights Prime Therapeutics /trending-topics-drug-approvals-june-2025-1 Prime Therapeutics’...

Formulary Watch: The new program, which begins in January 2025, provides members of Prime Therapeutics support for navigating utilization management requirements and finding financial assistance.

Event will feature David Lassen, chief clinical officer

Join Prime/Magellan Rx CEO Mostafa Kamal and Capital Rx CEO AJ Loiacono for their presentation, “Transformation within the pharmacy benefits ecosystem.”

Prime experts will dive into the latest trends in spend, disease categories and cost management strategies for payers.

Leslie Dickens, VP of operations and continuous improvement, joins experts in Dallas, Texas, to discuss the role and future of contact centers

Join us on Aug. 8 for a virtual conversation on how ERGs and BRGs can create more inclusive workplaces at Disability:IN Minnesota's August Member Meeting.

Prime moves up one spot to No. 2 in annual ranking

Prime experts will dive into the latest trends in spend, disease categories and cost management strategies for payers.

Dinesh Kandanchatha, chief information and technology officer at Prime Therapeutics, will join panelists in a Nov. 11 discussion about pressing issues facing health care

Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty...

Lowest net cost strategy helps enable provider, patient choice; helps ensure optimal, cost-effective therapy for complex inflammatory conditions.

Upcoming webinar on Nov. 6 shares more about Prime’s industry-leading ASHP-accredited PGY1 residency program

NCQA has awarded Prime Therapeutics LLC certification in Pharmacy Benefits

Prerak Parikh, PharmD, director of specialty clinical solutions at Prime Therapeutics/Magellan Rx Management, is named among 14 national 2024 Emerging Leaders in Healthcare Award recipients.